OCC.AX
Orthocell Ltd
Price:  
1.40 
AUD
Volume:  
1,025,936.00
Australia | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

OCC.AX WACC - Weighted Average Cost of Capital

The WACC of Orthocell Ltd (OCC.AX) is 7.7%.

The Cost of Equity of Orthocell Ltd (OCC.AX) is 7.65%.
The Cost of Debt of Orthocell Ltd (OCC.AX) is 4.30%.

Range Selected
Cost of equity 6.20% - 9.10% 7.65%
Tax rate 26.30% - 30.70% 28.50%
Cost of debt 4.00% - 4.60% 4.30%
WACC 6.2% - 9.1% 7.7%
WACC

OCC.AX WACC calculation

Category Low High
Long-term bond rate 4.0% 4.5%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.43 0.67
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.20% 9.10%
Tax rate 26.30% 30.70%
Debt/Equity ratio 0 0
Cost of debt 4.00% 4.60%
After-tax WACC 6.2% 9.1%
Selected WACC 7.7%

OCC.AX's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for OCC.AX:

cost_of_equity (7.65%) = risk_free_rate (4.25%) + equity_risk_premium (5.60%) * adjusted_beta (0.43) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.